Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Thornton & Ross kick off Combogesic TV campaign

Thornton & Ross have launched a new TV advertising campaign for Combogesic, an analgesic tablet combining paracetamol and ibuprofen.

The campaign, which hit screens on March 20, is designed to “buck the trend”, of adverts that are often “clinical in tone or show stereotyped sufferers”, the manufacturer said.

Comedy actress Sally Phillips delivers the voiceover, which gives it an “energetic and lively tone”, Thornton & Ross said.

The TV advert is part of a multimillion pound campaign running throughout 2017, which aims to introduce Combogesic as an alternative for those wanting to “step up” their pain relief, the manufacturer said.

Leanne Brook, senior brand manager at Thornton & Ross, said it hopes the advert is “memorable” and brings to life the benefits and application of the product.

A pack of 16 Combogesic tablets retails at £3.99, while 32 retail at £6.49.

To order, visit www.combogesichcp.co.uk or contact 01484 848200

Will you order this product?

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008683

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel